Work

Is HIV epidemic control by 2030 realistic?

Year: 2024

Type: article

Source: The Lancet HIV

DOI: 10.1016/s2352-3018(24)00098-5

Authors: Chris Beyrer, Georgia D Tomaras, Huub C Gelderblom, Glenda E Gray, Holly E Janes, Linda-Gail Bekker, Gregorio Millett, Giuseppe Pantaleo, Susan Buchbinder, Lawrence Corey

Institutions: Duke University, Fred Hutch Cancer Center, South African Medical Research Council, University of Cape Town, American Foundation for AIDS Research, Centre Hospitalier Universitaire Vaudois, University of Lausanne, San Francisco Department of Public Health

Language: English

Topic: HIV/AIDS Research and Interventions

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, Duke Global Health Institute, Duke University, Center for AIDS Research, University of Washington, National Institute of Allergy and Infectious Diseases

Awards: G1101234072, G1384187122, G2358037835, G7522203623, G9000009643, G9000028484, G9000165950, G9000250626, HIV Vaccine Trials Network Laboratory Center, HIV Vaccines Clinical Trials Network Leadership and Operations Center, SDMC: HIV Vaccine Trials Network, San Francisco Bay Clinical Trials Unit (CTU), Center for AIDS Research, Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program

OpenAlex ID: W4399933829

FWCI: 9.786

Cites: 23

Cited by: 31

Related to: 10